| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/17/2004 | CN1482242A A anti-enveloped virus recombinant polypeptide and its preparation method |
| 03/17/2004 | CN1482131A A segment differential nucleotide sequence of smallpox virus genom |
| 03/17/2004 | CN1482122A Intermediates for producing 2-thiosubstituted carbapenems |
| 03/17/2004 | CN1482118A Novel 5-hydroxy-3-carboxylate indoles derivant and method for preparing the same |
| 03/17/2004 | CN1482116A Coffee acyl naphthalene sulfonamides compound and method for preparing the same and anti HIV conformity enzyme action |
| 03/17/2004 | CN1481901A Hla matching donor-originating activated lymphocytes |
| 03/17/2004 | CN1481900A Specific IgY and composite IgY for Rheum and its novel formulation |
| 03/17/2004 | CN1481897A Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and use |
| 03/17/2004 | CN1481896A Interferon formulation of skin-infiltrating type |
| 03/17/2004 | CN1481893A Novel use of boninmycin in curing disease resulted from papillomavirus |
| 03/17/2004 | CN1481892A Reptile phrynosoma tablet for curing pulmonary disease |
| 03/17/2004 | CN1481886A Nanometer Chinese traditional medicine for prevention of atypical pneumonia |
| 03/17/2004 | CN1481885A Medication for HIV and its manufacturing process |
| 03/17/2004 | CN1481880A Ointment for curing tinea on manus and pedes |
| 03/17/2004 | CN1481876A Medication for virus hepatitis and hepatocirrhosis |
| 03/17/2004 | CN1481873A Novel preparation method for ageratum zhengqi capsule |
| 03/17/2004 | CN1481871A Compound Chinese traditional medicine formulation for hepatitis B and its preparation method |
| 03/17/2004 | CN1481869A Icterus-curing capsule for hepatitis B and its preparation method |
| 03/17/2004 | CN1481868A Novel use of prepared Chinese traditional medicine liushen pill |
| 03/17/2004 | CN1481867A Medication for preventing infection in hospital and method of preparing oral fluid |
| 03/17/2004 | CN1481864A Soup for detoxification |
| 03/17/2004 | CN1481862A Chinese traditional medicine composition curing viscera inflammation, toxin and endocrine disorder |
| 03/17/2004 | CN1481860A Medication for detoxifying and nourishing saliva and qi |
| 03/17/2004 | CN1481859A Capsule for regenerating bone |
| 03/17/2004 | CN1481857A Extract of rhizome of Chinese paris and its use |
| 03/17/2004 | CN1481856A Use of fruit oil of cubeb litsea as anti-candida medication |
| 03/17/2004 | CN1481834A Bear gall pill of benefiting the liver |
| 03/17/2004 | CN1481832A Polygonum capilalum extract , iIts preparation method and use |
| 03/17/2004 | CN1481824A Oral compositions for hiv-infected subjects |
| 03/17/2004 | CN1481805A Medication for hepatitis and its preparation method |
| 03/17/2004 | CN1481797A Composition comprising ketoconazole and sultifen |
| 03/17/2004 | CN1481792A Andrographolide soft capsule formulation and preparation method |
| 03/17/2004 | CN1481791A Andrographolide microcapsule and its preparation method |
| 03/17/2004 | CN1481785A Application of 1, 3-diphenyl-1, 3-propanedione in preparing medicine for treating hepatitis |
| 03/17/2004 | CN1142274C Polypeptide having cell withering promoting activity |
| 03/17/2004 | CN1142182C Macroweb bombinator antisperm polypeptide and its preparation process and use in medicine |
| 03/17/2004 | CN1142181C Giant web bombinator polypeptide and its application for preparing anticancer and anti-AIDS medicines |
| 03/17/2004 | CN1142171C 9-[2-[[[di (trimethylacetoxyl) methyl phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application |
| 03/17/2004 | CN1142170C 9-[2-[[[di (trimethylacetoxyl) methyl] phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application |
| 03/17/2004 | CN1142164C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substituent causing optical activity and process for preparing thereof |
| 03/17/2004 | CN1142162C Bicyclic oxazolidinones as antibacterial agents |
| 03/17/2004 | CN1142158C Process to prepare cyclic-sulfur fluorine containing oxazolidinones |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1141977C Improved virus vaccine |
| 03/17/2004 | CN1141956C Medicine for treating onychomycosis and its preparing process |
| 03/17/2004 | CN1141952C Medicine for curing shaoyang disease and its preparing method |
| 03/17/2004 | CN1141918C Process for preparing recombined heterobone with strong anti-infection power |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706859 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 03/16/2004 | US6706751 Dihydroindole and tetrahydroquinoline derivatives |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | US6706706 Non-nucleoside reverse transcriptase inhibitors |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706692 Staphylococci, streptococci, pneumococci |
| 03/16/2004 | US6706523 Nucleoprotein is mutated at the amino acid wherein phosphorylation occurs |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | US6706268 Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene |
| 03/16/2004 | CA2262500C Measles virus mutant antigen and gene coding for the same |
| 03/11/2004 | WO2004020635A1 Bacteriophages and remedies for bacterial infection |
| 03/11/2004 | WO2004020461A1 A group of novel synthetic antibiotic peptides |
| 03/11/2004 | WO2004020432A1 Arylamides |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004019982A1 Remedy |
| 03/11/2004 | WO2004019980A1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 03/11/2004 | WO2004019976A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 03/11/2004 | WO2004019963A1 Composition comprising crude drug extract having treating and preventing activity of hepatic disease caused by viral infection |
| 03/11/2004 | WO2004019942A1 Inverse agonists acting at virus-encoded g protein-coupled receptors |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019940A1 Method of preventing or treating atherosclerosis or restenosis |
| 03/11/2004 | WO2004019936A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | WO2004019934A1 Use of triptans as antiviral agents |
| 03/11/2004 | WO2004019929A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/11/2004 | WO2004019912A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 03/11/2004 | WO2004019911A2 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 03/11/2004 | WO2004019910A2 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2003097657A9 An antimicrobial agent |
| 03/11/2004 | WO2003096977A3 Methods of treating hepatitis |
| 03/11/2004 | WO2003092629A3 Methods of simultaneously treating mucositis and fungal infection |
| 03/11/2004 | WO2003092599A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003090679A3 11-deoxy azalide antibacterials |
| 03/11/2004 | WO2003089615A3 Antiviral inhibitions of capsid proteins |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003068164A3 Dosing regimen for gemcitabine hcv therapy |
| 03/11/2004 | WO2003068162A3 Modified fluorinated nucleoside analogues |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003063864A3 Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003046007A3 Treatment of micro-organism infection |
| 03/11/2004 | WO2003029288A3 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |